Evidence map›Paper›PMID 36601167›Full record

ArticleCureus2022

COVID-19 Vaccine Acceptance Among Pregnant and Lactating Women in Saudi Arabia.

Amal S Bagalb, Dlal Almazrou, Amani A Albraiki, Latifa I Alflaih, Lama O Bamunif

Abstract read
In one paragraph

Article in Cureus, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Amal S BagalbPharmaceutical Care Services, King Saud Medical City, Riyadh, SAU.
Dlal AlmazrouQuality, Saudi Central Board for Accreditation of Healthcare Institutions, Riyadh, SAU.
Amani A AlbraikiPharmaceutical Care Services, King Saud Medical City, Riyadh, SAU.
Latifa I AlflaihPharmaceutical Care Services, King Saud Medical City, Riyadh, SAU.
Lama O BamunifDepartment of Pharmacy Practice, College of Pharmacy, Princess Nourah Bint Abdulrahman University, Riyadh, SAU.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background The acceptance of vaccines among pregnant and breastfeeding women is vital to alleviate the risk of contracting and transmitting coronavirus disease 2019 (COVID-19). Therefore, we aimed to assess the COVID-19 vaccine acceptance among pregnant and breastfeeding/lactating women and the factors associated with the acceptance of the COVID-19 vaccine in Saudi Arabia. Methodology A cross-sectional survey was conducted among pregnant and breastfeeding women living in Saudi Arabia. A 23-item, self-administered questionnaire was used to assess the COVID-19 vaccine acceptance among pregnant or lactating women. Results A total of 160 (53.3%) pregnant women and 140 (46.7%) breastfeeding/lactating mothers participated in the study. When the participants were asked, "Have you been vaccinated or are you planning to take the vaccine during pregnancy or breastfeeding/lactation?" 164 (54.7%) responded with "Yes." When compared with breastfeeding/lactating mothers (54, 38.6%), pregnant women had more concerns about the efficacy and safety of COVID-19 vaccination (77 (48.1%); p = 0.043). The probability of rejecting COVID-19 vaccination was higher among breastfeeding/lactating women with a lower education level than those with a tertiary education level (odds ratio = 3.42, confidence interval = 1.24, 9.45, p = 0.018). Conclusions This study reported high acceptance of COVID-19 vaccination in a sample of breastfeeding/lactating women. Concern about vaccine safety among many pregnant women was the major reason for hesitancy. Factors such as low education, concerns regarding the efficacy and safety of the vaccine, and doctors' (e.g., obstetrician and gynecologist) recommendations for the COVID-19 vaccine were associated with vaccine acceptance.

Indexed as

covid-19 vaccinepregnant and lactatingpregnant femalesvaccine acceptancevaccine safety

Identifiers

PMID36601167
PMCPMC9805789

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.